VEGFA and neoplasm: In mouse tumor models, anti-VEGF treatment resulted in more mature DCs and less exhausted T cells intratumorally as well as reprograming of immunosuppressive M2-like macrophages into immune stimulatory M1-like macrophages (Malo et al., 2018; Huang et al., 2012).